MicroVision schedules business update and shareholder Q&A
MicroVision announced a business update and shareholder Q&A for June 25, 2026, featuring CEO Glen DeVos and the Board. The company also recently applied for a Nasdaq listing transfer and filed a Form S-3 registration statement.

*this image is generated using AI for illustrative purposes only.
MicroVision, Inc. will host a business update and interactive shareholder question-and-answer session on June 25, 2026, at 1:00 PM ET. The event aims to provide stakeholders with insights into the company's strategic progress and operational developments. This session follows the company's recent application to transfer its common stock listing from The Nasdaq Global Market to The Nasdaq Capital Market to secure a 180-day compliance period for the minimum bid price requirement.
CEO Glen DeVos, along with members of the Board of Directors and the Engineering team, will lead the presentation. The agenda includes introductory remarks, select pre-recorded video footage, and a live question-and-answer session covering a wide range of topics. Shareholders may participate via conference call or webcast, with questions accepted in advance or during the live event.
Participation Details
| Access Method | Details |
|---|---|
| Date & Time | June 25, 2026 at 1:00 PM ET |
| U.S./Canada Dial-in | 888-506-0062 |
| International Dial-in | 973-528-0011 |
| Passcode | 207657 |
| Webcast | Available on the Investor Relations website |
The company recommends participants log in 10 minutes early to ensure connection. An archive of the webcast and the full-length pre-recorded video will be available on MicroVision's Investor Relations website following the event. MicroVision recently filed a Form S-3 registration statement to replace an expiring shelf registration, maintaining its access to capital markets.
What specific strategic milestones does MicroVision aim to achieve during the 180-day compliance period to regain Nasdaq Global Market listing status?
How will the refreshed shelf registration via Form S-3 influence the company's capital allocation strategy over the next year?
What operational developments or product advancements are expected to be highlighted during the Q&A session with the Engineering team?


























